Medtronic CEO Pushes Back on Barclays Negative Comments

Posted in Medical Device

January 10, 2019 • 3 min read

Shares of Medtronic fell 6.5% after Medtronic CEO, Omar Ishrak, said during a presentation at the J.P. Morgan Healthcare Conference that sales would fall at the mid-point of the company's yearly projections due to softness in their cardiac and vascular divisions....

Amgen Reduces Price of Repatha Devices by 60%

Posted in Biotech

January 09, 2019 • 3 min read

On the first day of the J.P. Morgan Healthcare Conference, Amgen announced they would lower the list price of monthly doses for their cholesterol lowering medicine Repatha by 60%. ...

Medtronic and IBM Watson Health Launch New Prediction Feature for Hypoglycemia on Sugar.IQ Personal Diabetes Assistant App

Posted in Medical Device and Future of Healthcare

January 04, 2019 • 3 min read

Medtronic plc ($MDT) and its strategic technology partner, IBM ($IBM) Watson Health, announced a new feature for the Sugar.IQ personal diabetes assistant app called IQcast. Using artificial intelligence (AI) technology from IBM Watson Health, the feature aims to predict the likelihood of an individual experiencing a low glucose event within an upcoming 1-4 hour window....